Miguel R. Goncalves

Miguel R. Goncalves

Auto-generated profile, based on publicly available information

Miguel R. Goncalves

Centro Hospitalar Universitário de São João, Oporto, Portugal

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Respiratory Medicine
Verified
Journal Article
Open access
MCMichelle Chatwin
Michelle Chatwin
MTMichel Toussaint
Michel Toussaint
MGMiguel R. Gonçalves
Miguel R. Gonçalves
NSNicole Sheers
Nicole Sheers
UMUwe Mellies
Uwe Mellies
BMBrenda M. Morrow
Brenda M. Morrow
This is a unique state of the art review written by a group of 21 international recognized experts in the field that gathered during a meeting organized by the European Neuromuscular Centre (ENMC) in Naarden, March 2017. It systematically reports the entire evidence base for airway clearance techniques (ACTs) in both adults and children with neuromuscular disorders (NMD). We not only report randomised controlled trials, which in other systematic reviews conclude that there is a lack of evidence base to give an opinion, but also include case series and retrospective reviews of practice. For this review, we have classified ACTs as either proximal (cough augmentation) or peripheral (secretion mobilization). The review presents descriptions; standard definitions; the supporting evidence for and limitations of proximal and peripheral ACTs that are used in patients with NMD; as well as providing recommendations for objective measurements of efficacy, specifically for proximal ACTs. This state of the art review also highlights how ACTs may be adapted or modified for specific contexts (e.g. in people with bulbar insufficiency; children and infants) and recommends when and how each technique should be applied.

1 May 2010 in Chest
Verified
Journal Article
Closed access
PDF file
JBJohn Robert Bach
John Robert Bach
MGMiguel R. Gonçalves
Miguel R. Gonçalves
IHIrram Hamdani
Irram Hamdani
JWJoao Carlos Winck
Joao Carlos Winck

1 September 2004 in Chest
Verified
Journal Article
Closed access
JWJoao Carlos Winck
Joao Carlos Winck
MGMiguel R. Gonçalves
Miguel R. Gonçalves
CLCristina Lourenço
Cristina Lourenço
PVPaulo Viana
Paulo Viana
JAJoão Almeida
João Almeida
JBJohn R. Bach
John R. Bach

15 March 2012 in Critical Care
Verified
Journal Article
Open access
PDF file
MGMiguel R Gonçalves
Miguel R Gonçalves
THTeresa Honrado
Teresa Honrado
JWJoao Carlos Winck
Joao Carlos Winck
José-Artur PaivaJosé-Artur Paiva
José-Artur Paiva
Introduction: Weaning protocols that include noninvasive ventilation (NIV) decrease re-intubation rates and ICU length of stay. However, impaired airway clearance is associated with NIV failure. Mechanical insufflation-exsufflation (MI-E) has been proven to be very effective in patients receiving NIV. We aimed to assess the efficacy of MI-E as part of an extubation protocol. Method: Patients with mechanical ventilation (MV) for more than 48 hours with specific inclusion criteria, who successfully tolerated a spontaneous breathing trial (SBT), were randomly allocated before extubation, either for (A) a conventional extubation protocol (control group), or (B) the MI-E extubation protocol (study group). During the postextubation period (48 hours), group A patients received standard medical treatment (SMT), including NIV in case of specific indications, whereas group B received the same postextubation approach plus three daily sessions of mechanical in-exsufflation (MI-E). Reintubation rates, ICU length of stay, and NIV failure rates were analyzed. Results: Seventy-five patients (26 women) with a mean age of 61.8 ± 17.3 years were randomized to a control group (n = 40; mean SAPS II, 47.8 ± 17.7) and to a study group (n = 35; mean SAPS II, 45.0 ± 15.0). MV time before enrollment was 9.4 ± 4.8 and 10.5 ± 4.1 days for the control and the study group, respectively. In the 48 hours after extubation, 20 control patients (50%) and 14 study patients (40%) used NIV. Study group patients had a significant lower reintubation rate than did controls; six patients (17%) versus 19 patients (48%), P < 0.05; respectively, and a significantly lower time under MV; 17.8 ± 6.4 versus 11.7 ± 3.5 days; P < 0.05; respectively. Considering only the subgroup of patients that used NIV, the reintubation rates related to NIV failure were significantly lower in the study group when compared with controls; two patients (6%) versus 13 (33%); P < 0.05, respectively. Mean ICU length of stay after extubation was significantly lower in the study group when compared with controls (3.1 ± 2.5 versus 9.8 ± 6.7 days; P < 0.05). No differences were found in the total ICU length of stay. Conclusion: Inclusion of MI-E may reduce reintubation rates with consequent reduction in postextubation ICU length of stay. This technique seems to be efficient in improving the efficacy of NIV in this patient population.

1 March 2013 in American Journal of Physical Medicine & Rehabilitation
Verified
Journal Article
Closed access
JBJohn R. Bach
John R. Bach
MGMiguel R. Gonçalves
Miguel R. Gonçalves
AHAlice Hon
Alice Hon
YIYuka Ishikawa
Yuka Ishikawa
EVEduardo Luis De Vito
Eduardo Luis De Vito
MDMarie Eugenia Dominguez
Marie Eugenia Dominguez
Respiratory management of patients with end-stage respiratory muscle failure of neuromuscular disease has evolved from no treatment and inevitable respiratory failure to the use of up to continuous noninvasive intermittent positive pressure ventilatory support (CNVS) to avert respiratory failure and to permit the extubation of "unweanable" patients without tracheostomy. An international panel experienced in CNVS was charged by the 69th Congress of the Mexican Society of Pulmonologists and Thoracic Surgeons to analyze changing respiratory management trends and to make recommendations. Neuromuscular disease respiratory consensuses and reviews were identified from PubMed. Individual respiratory interventions were identified; their importance was established by assessing the quality of evidence-based literature for each one and their patterns of use over time. The panel then determined the evidence-based strength for the efficacy of each intervention and made recommendations for achieving prolonged survival by CNVS. Fifty publications since 1993 were identified. Continuous positive airway pressure, oxygen therapy, bilevel positive airway pressure used at both low and high spans, "air stacking," manually assisted coughing, low pressure (23 hrs per day; CNVS), extubation and decannulation of ventilator-dependent patients to CNVS, and oximetry feedback for noninvasive positive pressure ventilation and mechanically assisted coughing were identified. All noted interventions are being used with increasing frequency and were unanimously recommended to achieve prolonged survival by CNVS, with the exception of supplemental oxygen and continuous positive airway pressure, which are being used less and were not recommended for this population. CNVS and extubation of unweanable patients to CNVS are increasingly being used to prolong life while avoiding invasive interfaces.

1 March 2018 in Neuromuscular Disorders
Verified
Journal Article
Closed access
MTMichel Toussaint
Michel Toussaint
MCMichelle Chatwin
Michelle Chatwin
JGJesus Gonzales
Jesus Gonzales
DBDavid J. Berlowitz
David J. Berlowitz
DBDavid J Berlowitz
David J Berlowitz
JCJohann Chaulet
Johann Chaulet